It is possible that in someone with mutations in the SLC2A9 gene could be susceptible to parkinsonism from low uric acid levels. PPIs can decrease uric acid and potentially further worsen the effect of the enzyme inhibition.
Parkinson's runs in my family and we do have low serum uric acid and an SLC2A9 mutation. Although I have not been diagnosed with Parkinson's, when I was put on a PPI during a hospital stay I developed tremors. They diminished after discontinuing the medication.
From clinical experience, I was not aware of a relationship between PPI's and parkinsonism. Your question is very interesting espcially when a large number of patients with parkinsonsim are prescribed oral PPI's for reflux.
Yes, a lot of Parkinson's disease patients are prescribed such medication.
So if PPI could induce or worsen parkinsonian symptoms, the problem is very complicated. In Japan, some herbal medicine can also be used for treatment of reflux.
I would face the question from another point of view.
The B12 deficiency is related with the development of many CNS symptoms which could mimick a parkinsonism.
The use of omeprazole, the first PPI, is a known risk factor of B12 deficiency, so, it could be interesting to know the actual symptoms (tremor, bradicinesia, rigidity, hypokinesia, etcétera). The determination of vitamin B12 and folic acid is included in the differential diagnosis during the first interviews in parkinsonism. In Parkinson disease, reflux, nausea and / or vomiting is treated more commonly with prokinetic drug as domperidone (although recently linked to problems of cardiac arrhythmia at extreme ages of life).